Sheaff Brock Investment Advisors, LLC Intercept Pharmaceuticals, Inc. Transaction History

Sheaff Brock Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$24.48 - $42.47 $139,536 - $242,079	-5,700 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$39.09 - $53.44 $222,813 - $304,608	5,700 New	5,700 $236,000
Q3 2018 Nov 09, 2018	SELL	$88.49 - $127.55 $278,743 - $401,782	-3,150 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$60.0 - $85.67 $189,000 - $269,860	3,150 New	3,150 $264,000
Q3 2017 Nov 13, 2017	SELL	$57.01 - $118.75 $179,581 - $374,062	-3,150 Closed	0 $0
Q2 2017 Aug 09, 2017	BUY	N/A	3,150	3,150 $381,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.